ZenoBio

Ahmedabad, India Founded: 2011 • Age: 15 yrs
Develops and delivers medicines for regulating body processes.

About ZenoBio

ZenoBio is a company based in Ahmedabad (India) founded in 2011. It operates as a B2B. The company has 17 employees. ZenoBio offers products and services including Therapeutic Medicines and Vitamin D3 Supplements. ZenoBio operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Key Metrics
  • Annual Revenue
    ₹2.61 Cr

    FY 2024 · +2% YoY

  • Net Profit
    ₹21.3 Lakh

    FY 2024 · 8% margin

  • EBITDA
    ₹22.8 Lakh

    FY 2024 · 9% margin

  • Employee Count
    17

Products & Services of ZenoBio

ZenoBio offers a comprehensive portfolio of products and services, including Therapeutic Medicines and Vitamin D3 Supplements.

Therapeutic Medicines
Pharmaceuticals

Medicines that restore and regulate body processes for health

Vitamin D3 Supplements
Nutraceuticals

Supplements providing essential Vitamin D3 for body functions

Board of directors of Zenobio Life Sciences Private Limited (ZenoBio)

Zenobio Life Sciences Private Limited is the primary company behind ZenoBio. The boards of the 2 registered companies of ZenoBio currently have 5 directors; the longest-serving is Savani Odhavjibhai Dharmesh, appointed in 2012. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Savani Odhavjibhai Dharmesh
DIN 05290235
Director28 May 201214 yrs 4 moZenobio Life Sciences Private Limited
Sachin Motibhai Prajapati
DIN 06954599
Director16 Jun 201511 yrs 3 moZenobio Life Sciences Private Limited
Mrunal Kantibhai Prajapati
DIN 06954586
Director16 Jun 201511 yrs 3 moZenobio Life Sciences Private Limited
Sweni Shah
DIN 08728858
Designated Partner20 Mar 20206 yrs 6 moAurshine Jewels Llp
Kevin Shah Rajnikant
DIN 03008805
Designated Partner20 Mar 20206 yrs 6 moAurshine Jewels Llp, Zenobio Life Sciences Private Limited

Financials of ZenoBio

Figures of Zenobio Life Sciences Private Limited, the primary company behind ZenoBio, for FY 2024. Revenue was ₹2.61 Cr (+2% year on year). Net profit was ₹21.3 Lakh (8% margin). EBITDA was ₹22.8 Lakh (9% margin). Revenue has grown at a compounded annual rate of +19% over three years and +2% over five years.

  • ₹2.61 CrRevenue · FY 2024 · +2% YoY
  • ₹21.3 LakhNet profit · 8% margin
  • ₹22.8 LakhEBITDA · 9% margin
  • ₹20 LakhPaid-up capital
  • 17Employees (provident fund records)
  • +19%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Zenobio Life Sciences Private Limited are on its company page.

Premium access

Detailed financial statements for ZenoBio

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of ZenoBio

ZenoBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
unither-pharma.com1993Paris, France––
Contract development and manufacturing organization for proprietary and generic drugs
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India––
Company offering a suite of R&D and manufacturing services for small molecules and generics
recipharm.com1995Jordbro, Sweden–1,083
Pharmaceutical development and manufacturing services are offered contractually.
corerxpharma.com2006Clearwater, United States$15M–
CDMO with a focus on early phase drug product development
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
windlas.com2001Gurugram, India$12.96M1,264
Biopharma regulatory affairs, quality control, and strategy services are provided.
medpharm.com1998Guildford, United Kingdom–108
Topical and inhaled drug delivery formulations are developed and manufactured.
Premium access

Detailed competitors of ZenoBio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to ZenoBio

10 companies that operate in the same segment as ZenoBio (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 27.35 M362
Plant-based frozen meals are delivered via weekly subscriptions.
2016London, England, United KingdomUSD 69.9 MUSD 12.54 M146
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M––
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M––
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 80.12 M––
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M––
Cellular health supplements for metabolic repair are developed and manufactured.
2014New York, New York, United StatesUSD 66.1 M––
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 23.98 M–
Low-carb products for weight loss are provided by Atkins.
1960Denver, Colorado, United StatesUSD 15 M––
Synbiotic supplements and fermented products for gut health are provided.
2021Mumbai, Maharashtra, IndiaUSD 20.02 MUSD 5.14 M88
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ZenoBio

ZenoBio was founded in 2011.

ZenoBio is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

ZenoBio has 17 employees.

The primary company behind ZenoBio, Zenobio Life Sciences Private Limited, reported revenue of β‚Ή2.61 Cr for FY 2024, up 2% year on year.

Zeno Bio LifeSciences is a pharmaceutical company based in Ahmedabad, India, founded in 2012. It focuses on discovering, developing, and delivering healthcare solutions that restore, restart, and regulate fundamental body processes for patients and physicians. The company emphasizes innovation in medicines and forms partnerships to enhance capabilities. It serves global needs through therapeutic approaches aimed at optimal well-being, combining expertise with forward-thinking strategies.

ZenoBio's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

ZenoBio offers Therapeutic Medicines and Vitamin D3 Supplements.

ZenoBio is associated with 2 legal entities: Zenobio Life Sciences Private Limited, Aurshine Jewels Llp.

The legal entities of ZenoBio currently have 5 directors, including Sweni Shah, Kevin Shah Rajnikant, Sachin Motibhai Prajapati and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available